A Study to Examine the Efficacy of a Therapeutic THX-110 for Obstructive Sleep Apnea

Phase 2 Unknown 30 enrolled Neurothera Labs Inc.

NaSingle-groupOpen-labelTreatment

Summary

This is a sponsored proof of concept study with the purpose to examine the safety, tolerability and feasibility of THX-110 (Dronabinol (synthetic Δ9-THC) and PEA) for the treatment of adults with Obstructive Sleep Apnea.

Timeline

Start: 2018-06-04
Primary completion: 2019-04
Completion: 2019-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dronabinol	Other / unclassified	10 mg	—
Background	PEA	Unknown	800 mg	—

A Study to Examine the Efficacy of a Therapeutic THX-110 for Obstructive Sleep Apnea

Summary

Timeline

Drugs

Indications